Stay updated with breaking news from Thyroid Disorder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
All patients with advanced thyroid disease and most patients with incurable radioiodine refractory differentiated thyroid cancer should undergo somatic mutational testing, say experts.
COVID-19 may disrupt the endocrine system, making people vulnerable to thyroid, pituitary, and gonad issues even after recovery.
A prospective, randomized trial provides further evidence that use of radioiodine ablation after surgery for low-risk differentiated thyroid cancer does not result in any benefit.
In an observational, single-center, New Zealand study of 222 patients with thyrotoxicosis, treatment with radioiodine led to frequent cures but left many needing thyroxine maintenance.
A retrospective review of more than 1800 presumably benign thyroidectomy specimens showed that 9% contained papillary thyroid microcarcinomas.